- Home
- AXDX vs DXR Comparison
AXDX vs DXR Comparison
Compare AXDX & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXDX
- DXR
- Stock Information
- Founded
- AXDX 1982
- DXR 1970
- Country
- AXDX United States
- DXR United States
- Employees
- AXDX N/A
- DXR N/A
- Industry
- AXDX Biotechnology: Laboratory Analytical Instruments
- DXR Medical/Dental Instruments
- Sector
- AXDX Industrials
- DXR Health Care
- Exchange
- AXDX Nasdaq
- DXR Nasdaq
- Market Cap
- AXDX 44.5M
- DXR 42.6M
- IPO Year
- AXDX 1996
- DXR N/A
- Fundamental
- Price
- AXDX $1.85
- DXR $9.01
- Analyst Decision
- AXDX Hold
- DXR Strong Buy
- Analyst Count
- AXDX 1
- DXR 1
- Target Price
- AXDX $1.00
- DXR $24.75
- AVG Volume (30 Days)
- AXDX 61.8K
- DXR 7.6K
- Earning Date
- AXDX 11-07-2024
- DXR 01-01-0001
- Dividend Yield
- AXDX N/A
- DXR N/A
- EPS Growth
- AXDX N/A
- DXR N/A
- EPS
- AXDX N/A
- DXR 0.35
- Revenue
- AXDX $11,909,000.00
- DXR $154,205.00
- Revenue This Year
- AXDX $1.42
- DXR N/A
- Revenue Next Year
- AXDX $4.09
- DXR N/A
- P/E Ratio
- AXDX N/A
- DXR $25.85
- Revenue Growth
- AXDX N/A
- DXR N/A
- 52 Week Low
- AXDX $0.73
- DXR $7.11
- 52 Week High
- AXDX $5.52
- DXR $10.04
- Technical
- Relative Strength Index (RSI)
- AXDX 48.99
- DXR 49.80
- Support Level
- AXDX $1.77
- DXR $8.53
- Resistance Level
- AXDX $2.04
- DXR $9.10
- Average True Range (ATR)
- AXDX 0.11
- DXR 0.47
- MACD
- AXDX -0.01
- DXR -0.01
- Stochastic Oscillator
- AXDX 29.63
- DXR 35.71
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.